These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 17942309)
1. Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification. Heightman TD; Scott JS; Longley M; Bordas V; Dean DK; Elliott R; Hutley G; Witherington J; Abberley L; Passingham B; Berlanga M; de Los Frailes M; Wise A; Powney B; Muir A; McKay F; Butler S; Winborn K; Gardner C; Darton J; Campbell C; Sanger G Bioorg Med Chem Lett; 2007 Dec; 17(23):6584-7. PubMed ID: 17942309 [TBL] [Abstract][Full Text] [Related]
2. Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation. Witherington J; Abberley L; Briggs MA; Collis K; Dean DK; Gaiba A; King NP; Kraus H; Shuker N; Steadman JG; Takle AK; Sanger G; Wadsworth G; Butler S; McKay F; Muir A; Winborn K; Heightman TD Bioorg Med Chem Lett; 2008 Mar; 18(6):2203-5. PubMed ID: 18316188 [TBL] [Abstract][Full Text] [Related]
3. Motilin and ghrelin as prokinetic drug targets. De Smet B; Mitselos A; Depoortere I Pharmacol Ther; 2009 Aug; 123(2):207-23. PubMed ID: 19427331 [TBL] [Abstract][Full Text] [Related]
4. A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water. Camilleri M; Acosta A Neurogastroenterol Motil; 2013 Nov; 25(11):859-63. PubMed ID: 24001134 [TBL] [Abstract][Full Text] [Related]
5. Effect of chronic stress on gastric emptying and plasma ghrelin levels in rats. Ochi M; Tominaga K; Tanaka F; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Higuchi K; Arakawa T Life Sci; 2008 Apr; 82(15-16):862-8. PubMed ID: 18343456 [TBL] [Abstract][Full Text] [Related]
6. Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic. Hoveyda HR; Marsault E; Gagnon R; Mathieu AP; Vézina M; Landry A; Wang Z; Benakli K; Beaubien S; Saint-Louis C; Brassard M; Pinault JF; Ouellet L; Bhat S; Ramaseshan M; Peng X; Foucher L; Beauchemin S; Bhérer P; Veber DF; Peterson ML; Fraser GL J Med Chem; 2011 Dec; 54(24):8305-20. PubMed ID: 22106937 [TBL] [Abstract][Full Text] [Related]
7. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Depoortere I; De Winter B; Thijs T; De Man J; Pelckmans P; Peeters T Eur J Pharmacol; 2005 May; 515(1-3):160-8. PubMed ID: 15890336 [TBL] [Abstract][Full Text] [Related]
9. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging. Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963 [TBL] [Abstract][Full Text] [Related]
10. Ghrelin receptor agonists: a new class of prokinetic agents. Neurogastroenterol Motil; 2010 Oct; 22(10):1043-4. PubMed ID: 20840719 [No Abstract] [Full Text] [Related]
12. Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro. Qiu WC; Wang ZG; Wang WG; Yan J; Zheng Q Chin Med J (Engl); 2008 Jul; 121(13):1183-8. PubMed ID: 18710636 [TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR). Zhai W; Flynn N; Longhi DA; Tino JA; Murphy BJ; Slusarchyk D; Gordon DA; Pendri A; Shi S; Stoffel R; Ma B; Sofia MJ; Gerritz SW Bioorg Med Chem Lett; 2008 Sep; 18(18):5083-6. PubMed ID: 18722770 [TBL] [Abstract][Full Text] [Related]
14. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity. Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin and motilin receptor agonists: a long and winding misconception. Camilleri M Neurogastroenterol Motil; 2013 Dec; 25(12):1003. PubMed ID: 24251874 [No Abstract] [Full Text] [Related]
16. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Dornonville de la Cour C; Lindström E; Norlén P; Håkanson R Regul Pept; 2004 Aug; 120(1-3):23-32. PubMed ID: 15177917 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist. Fraser GL; Hoveyda HR; Tannenbaum GS Endocrinology; 2008 Dec; 149(12):6280-8. PubMed ID: 18719021 [TBL] [Abstract][Full Text] [Related]
18. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. Moulin A; Demange L; Bergé G; Gagne D; Ryan J; Mousseaux D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J J Med Chem; 2007 Nov; 50(23):5790-806. PubMed ID: 17927165 [TBL] [Abstract][Full Text] [Related]
19. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor. Holst B; Frimurer TM; Mokrosinski J; Halkjaer T; Cullberg KB; Underwood CR; Schwartz TW Mol Pharmacol; 2009 Jan; 75(1):44-59. PubMed ID: 18923064 [TBL] [Abstract][Full Text] [Related]
20. Ghrelin and motilin receptor agonists: a long and winding misconception. Sanger GJ Neurogastroenterol Motil; 2013 Dec; 25(12):1002. PubMed ID: 24112245 [No Abstract] [Full Text] [Related] [Next] [New Search]